Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
Asian Journal of Andrology · 2025
DOI: 10.4103/aja2024115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, 2025. Verfasst von Wei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Southeast University, Nanjing 210000, China. Hauptthemen laut MEDLINE: Erectile Dysfunction, Mesenchymal Stem Cell Transplantation, Penis, Peripheral Nerve Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Stem cell treatment may enhance erectile dysfunction (ED) in individuals with cavernous nerve injury (CNI). Nevertheless, no investigations have directly ascertained the implications of varying amounts of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) on ED. We compare the efficacy of three various doses of HUC-MSCs as a therapeutic strategy for ED. Sprague–Dawley rats (total = 175) were randomly allocated into five groups. A total of 35 rats underwent sham surgery and 140 rats endured bilateral CNI and were treated with vehicles or doses of HUC-MSCs (1 × 10 6 cells, 5 × 10 6 cells, and 1 × 10 7 cells in 0.1 ml, respectively). Penile tissues were harvested for histological analysis on 1 day, 3 days, 7 days, 14 days, 28 days, 60 days, and 90 days postsurgery. It was found that varying dosages of HUC-MSCs enhanced the erectile function of rats with bilateral CNI and ED. Moreover, there was no significant disparity in the effectiveness of various dosages of HUC-MSCs. However, the expression of endothelial markers (rat endothelial cell antigen-1 [RECA-1] and endothelial nitric oxide synthase [eNOS]), smooth muscle markers (alpha smooth muscle actin [α-SMA] and desmin), and neural markers (neurofilament [RECA-1] and neurogenic nitric oxide synthase [nNOS]) increased significantly with prolonged treatment time. Masson’s staining demonstrated an increased in the smooth muscle cell (SMC)/collagen ratio. Significant changes were detected in the microstructures of various types of cells. In vivo imaging system (IVIS) analysis showed that at the 1 st day, the HUC-MSCs implanted moved to the site of damage. Additionally, the oxidative stress levels were dramatically reduced in the penises of rats administered with HUC-MSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Southeast University, Nanjing 210000, China.
- Department of Urology, Xuzhou Central Hospital, Xuzhou 221000, China.
- Department of Central Laboratory, Xuzhou Central Hospital, Xuzhou 221000, China.
- Department of Urology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, China.
- School of Medicine, Jiangsu University, Zhenjiang 212000, China.
- Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250000, China.
Zitieren
APA
Wang, W., Liu, Y., Zhou, Z. H., Pang, K., Wang, J. K., Huan, P. F., Lu, J. R., Zhu, T., Zhu, Z. B., & Han, C. H. (2025). Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model. Asian Journal of Andrology. https://doi.org/10.4103/aja2024115
Vancouver
Wang W, Liu Y, Zhou ZH, Pang K, Wang JK, Huan PF, et al. Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model. Asian Journal of Andrology. 2025. doi:10.4103/aja2024115
BibTeX
@article{Wang2025,
author = {Wang, Wei and Liu, Ying and Zhou, Zi-Hao and Pang, Kun and Wang, Jing-Kai and Huan, Peng-Fei and Lu, Jing-Ru and Zhu, Tao and Zhu, Zuo-Bin and Han, Cong-Hui},
title = {Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model},
journal = {Asian Journal of Andrology},
year = {2025},
doi = {10.4103/aja2024115}
}
EUVIMED